A plethora of #oncopharm updates!

Isatuximab is approved and neratinib gets another breast cancer indication (2:00)

Pembrolizumab with chemo for triple-negative breast cancer (8:50)

New EPOC updated survival analysis on FOLFOX+cetuximab in isolated liver metastatic colon cancer (15:00)

Precision medicine in pancreatic cancer (19:30)

Cladribine + rituximab for hairy cell leukemia (23:30)

Isatuximab is approved and neratinib gets another breast cancer indication

Pembrolizumab with chemo for triple-negative breast cancer

New EPOC updated survival analysis on FOLFOX+cetuximab in isolated liver metastatic colon cancer

Cladribine + rituximab for hairy cell leukemia

Viz-Aflibercept Pricing: A Case Study

OncoPharm is a podcast dedicated to all things oncology pharmacy.  Most episodes cover updates and recent publications concerning the use of medications in caring for patients we cancer.  Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.